MicroPort MedBot-B (2252.HK) opened sharply lower and trended downward in the morning session, closing at 09:49 BJ at HK$20.86, down 5.18%, with the intraday low at HK$20.86 and the open at HK$22.00 marking the session high, forming a surge-and-retreat pattern. The decline was driven by concerns over corporate governance after the company postponed its board meeting to review interim results and announced the resignation of executive director Yu Liu, dampening the optimism from its first-ever semi-annual profit guidance (forecasted net profit for 1H 2026). On the earnings front, Q4 2025 revenue surged 148.32% YoY to HK$208.7 million, while net loss narrowed 60.99% YoY, indicating solid operational improvement. However, the current price of HK$20.86 remains well below its 20-day MA of HK$23.48 and 60-day MA of HK$23.21, and is 40.97% below its 52-week high of HK$35.34, with a high PB ratio of 47.32x, reflecting persistent market skepticism about profitability sustainability. While the net profit margin narrowed to -36.31% in Q4 2025, a sustained earnings turnaround could provide a floor for the stock.